SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Melio names Boaz BenDavid as its first Chief Financial Officer

Check Point registers higher than expected Q1 profit helped by growth of AI-powered security platform

Microsoft explains how Generative AI impacts IP law and compliance

Airwallex sees Israel as a key player in the GenAI space

Buzz

Most popular

Daily

Weekly

1

Nvidia on verge of completing $700 million acquisition of Run:ai

2

Nvidia announces $700 million acquisition of Run:ai

3

Israeli Billionaire Hires Black Cube to Spy on Former Partner Company Vale

4

Nvidia continues Israel shopping spree with acquisition of Deci

5

Nagomi Security raises $23 million Series A for proactive defense platform

Gamida Cell

5 stories about Gamida Cell

ג'וליאן אדמס מנכ"ל גמידה

Gamida Cell announces $75 million financing with Highbridge Capital Management

The Israeli company is developing and commercializing cures for blood cancers and serious hematologic diseases

Gamida Cell Downprices Shares to Raise $50 Million Nasdaq IPO

28.10.18|Lilach Baumer

The Israel-based biotech company offered its shares at $8, below its previous intention of $13 to $15 per share

נאסד"ק וול סטריט

Novartis-Backed Gamida Downgrades Nasdaq IPO Expectations to $50-$60 Million

18.10.18|Lilach Baumer

The Jerusalem-based biotech company filed for a $69 million initial public offering in September but disclosed no pricing terms

נאסד"ק וול סטריט

Biotech Company Gamida Cell Files for $69 Million Nasdaq IPO

30.09.18|Dror Reich

The Jerusalem-based company develops cellular and immune therapies. Its lead product is a universal bone marrow transplant solution

המדען הראשי ב כלל ביוטכנולוגיה ד"ר ג'וליאן אדמס

Pharma Veteran Julian Adams takes Helm at Gamida Cell

21.11.17|Lilach Baumer

The Novartis-backed company is developing a universal bone marrow transplant solution for patients unable to find a donor